Sep 10, 2025, 01:01 AM by User Not Found

Bio-IT World | At the J.P. Morgan Healthcare Conference in January, sequencing company after sequencing company laid out their vision for 2025: the year of the proteome. Illumina joined the chorus. Jacob Thaysen, Illumina’s CEO, highlighted proteomics as a particularly exciting area of focus.

Sep 9, 2025, 11:02 AM by User Not Found

Bio-IT World | Modern medical practices like antibiotics and C-sections, coupled with an industrialized food system that prioritizes high yields and profitability over nutritional quality, have left most babies born today lacking the gut microbes they need before kindergarten to train their immune system for life. The deficiency in these types of Bifidobacterium affects all but a fraction of infants in the United States, putting them at risk for developing atopic disease conditions that include food allergies, eczema, and asthma.

Sep 5, 2025, 08:12 AM by

Gifthealth today announced its acquisition of Occam Health Services creating the first-of-its-kind digital pharmacy platform and patient access hub solution fundamentally shifting how biopharma companies accelerate access and value for patients.

Sep 5, 2025, 08:12 AM by

Ginkgo Datapoints and Apheris have partnered to form the Antibody Developability Consortium, which aims to address the challenge of predicting and optimizing antibody properties early in the research and development process. The consortium combines Ginkgo's high-throughput experimental capabilities for generating AI-ready datasets with Apheris's federated computing infrastructure, allowing members to securely collaborate on sensitive data.

Sep 4, 2025, 09:23 AM by

One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical development, announced today the successful completion of a planned seed extension to accelerate its software platform development.

Sep 4, 2025, 09:23 AM by

Sep 4, 2025, 09:23 AM by

MultiOmic Health Limited (“MOH”), an artificial intelligence (AI)-enabled precision medicine biotechnology company, and BIO4 Campus (“BIO4”), the Republic of Serbia's flagship biotechnology and life sciences hub, today announced the signing of a Memorandum of Understanding (MoU) to explore collaborative opportunities in biomedicine, biotechnology and bioinformatics, with a strong emphasis on AI applications.

Sep 4, 2025, 09:23 AM by

Sep 4, 2025, 09:23 AM by

Elsevier launches PharmaPendium AI - a generative AI assistant for regulatory intelligence in drug development.

Sep 4, 2025, 09:23 AM by

Sep 4, 2025, 01:00 AM by User Not Found

Bio-IT World| Researchers in Denmark report finding a potential new route for developing microbiome-based therapies by providing “a concrete example” of how specific bacterial proteins might be used in the treatment of chronic metabolic diseases. Specifically, they identified a common gut bacterium capable of producing hormone-like proteins measurably influencing weight, bone density, and blood sugar regulation in preclinical models.

Sep 3, 2025, 08:00 AM by

Sep 3, 2025, 08:00 AM by

Ametris (formerly ActiGraph), a global digital health solutions provider transforming real-world patient data into validated clinical evidence, announced the launch of Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) in Obesity.

Sep 3, 2025, 08:00 AM by

PhenoTips, based in Toronto, has developed a first-of-its-kind cloud-based software that streamlines and digitizes genomic health record management, saving clinicians time and supporting precision medicine initiatives. In June 2025, PhenoTips was one of 13 Ontario-based life sciences companies to receive the renewed Life Sciences Innovation Fund from the government of Ontario, through the Ontario Centre of Innovation (OCI).

Sep 3, 2025, 08:00 AM by

• New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior • End-to-end support from experimental design to data interpretation

Sep 3, 2025, 01:00 AM by User Not Found

Bio-IT World| A large segment of the population holds negative views towards psychedelics, even in therapeutic contexts. Up until a few years ago, those people included Kosuke Kato, Ph.D., assistant professor of medicine at Baylor College of Medicine. His perspective changed when he and Louise Hecker, Ph.D., then working at Emory University, began reading up on the experimental use of psilocybin in treating various psychiatric and age-related neurodegenerative diseases.

Sep 2, 2025, 01:00 AM by User Not Found

Bio-IT World | Researchers at the Icahn School of Medicine at Mount Sinai have published a machine learning model to predict penetrance of genetic variants—how likely the variants are to cause disease. The tool combines genomic and clinical phenotype data to evaluate penetrance at scale, offering refined, individualized disease risk estimates. The study was published last week in Science (DOI: 10.1126/science.adm7066).

Aug 28, 2025, 10:01 AM by

Aug 28, 2025, 10:01 AM by

Rousselot announces promising preclinical results from a study conducted by Cellbricks Therapeutics, a Berlin-based biotech startup and spin-off from the Technical University of Berlin. As a pioneer in 3D-bioprinting, Cellbricks successfully implanted 3D-bioprinted adipose tissue constructs into mice, with no signs of fibrosis or rejection observed after seven weeks.

Aug 28, 2025, 10:01 AM by

• Qureight’s advanced AI 3D imaging platform to be used across clinical trial to evaluate anatomical lung changes in adult patients, including during patient enrolment • CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF